Haddon Heights, New Jersey Clinical Trials
A listing of Haddon Heights, New Jersey clinical trials actively recruiting patient volunteers.
Found 85 clinical trials
A Study of SY 5609 a Selective CDK7 Inhibitor in Advanced Solid Tumors
This is a dose escalation study and will be the first to administer SY-5609 alone to humans with select advanced solid tumors and in combination with Fulvestrant to patients with HR positive, HER2-negative breast cancer.
- 0 views
- 19 Feb, 2024
- +4 other locations
Wells and Enteric Disease Transmission Trial (WET - Trial)
Approximately 40 million people in the US are served by private wells, many of which are untreated. The investigators estimate that 1.29 million cases of gastrointestinal illness (GI) per year are attributed to consuming water from untreated private wells in the US. These cases of GI can cause a significant …
- 0 views
- 19 Feb, 2024
- 1 location
Phase 2 Trial of CD19 Redirected Autologous T Cells
This is an open-label, four-cohort, phase 2 study to determine the efficacy of CART19 in pediatric and young adult patientswith hypodiploid (Cohort A) or t(17;19) B-ALL (Cohort B), infants with very high risk KMT2A B-ALL (Cohort C), and in patients with central nervous system (CNS) relapse who did not receive …
- 0 views
- 19 Feb, 2024
- 1 location
Tipifarnib for the Treatment of Advanced Solid Tumors Lymphoma or Histiocytic Disorders With HRAS Gene Alterations a Pediatric MATCH Treatment Trial
This phase II pediatric MATCH trial studies how well tipifarnib works in treating patients with solid tumors that have spread to other places in the body (advanced), lymphoma, or histiocytic disorders that have HRAS genetic alterations. Tipifarnib may block the growth of cancer cells that have specific genetic changes in …
- 0 views
- 19 Feb, 2024
- +82 other locations
PCSK9i in AAA1236
Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol
- 0 views
- 04 Mar, 2025
- +1 other locations
PCSK9i in AAA1237
Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol
- 0 views
- 07 May, 2025
- +1 other locations
PCSK9i in AAA1240
Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol
- 0 views
- 09 May, 2025
- +1 other locations
PCSK9i in AAA1241
Please see section 3 of the full protocol Please see section 3 of the full protocol Please see section 3 of the full protocol
- 0 views
- 13 May, 2025
- +1 other locations
IBI3014 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
This is a phase 1/2 multicenter, multi-regional, open-label, first-in-human study of IBI3014 in participants with unresectable locally advanced or metastatic solid tumors.
- 0 views
- 22 Aug, 2025
- +1 other locations